CClinicalTrials.gg
RecruitingNCT07378696LOCI-FIN-PUpdated Feb 5, 2026

Implementing Evidence-Based Nursing: Leadership and Organizational Change for Implementation

An interventional study of Leadership and organizational change for implementation in Leadership, Self-Harm and Malnutrition Elderly, sponsored by Jaakko Varpula. Recruiting at 1 site in Finland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-05.

Sponsored by Jaakko Varpula · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Started Jan 2026; still recruiting 8 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
300
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

This study aims to find out whether a leadership and organizational development program called the LOCI (Leadership and Organizational Change for Implementation) strategy can help nurses and their managers use the best available research in everyday care. Using evidence-based practice.

Previous work in the region showed that nurses and their managers want to use evidence-based practices but face challenges, such as unclear processes, limited support, and differences in skills. The LOCI strategy has helped leaders in other countries improve how new practices are introduced and supported. This study will test a version of LOCI adapted for Finnish healthcare settings.

Nurse managers and staff from selected hospital and elder care units will:

Take part in leadership and training sessions. Receive individual and group mentoring. Work with their teams on plans that support introducing new, research-based ways of working.

Two evidence-based practices will be introduced:

In psychiatric units: A safety planning method to help prevent suicide among people receiving mental health care.

In elder care units: Better ways to identify and treat malnutrition among older adults.

The study involves:

Nurse managers Nursing staff Senior nurse leaders Specialist nurses who support the training

The study will run for one year. The LOCI program lasts nine months, followed by a three-month follow-up period.

Assessment:

How well the adapted LOCI strategy works in practice (for example, whether participants find it useful).

Whether leadership skills and workplace support for evidence-based practices improve.

Whether the new care practices (suicide safety planning and malnutrition prevention) are used more often and more effectively.

Participants will complete questionnaires, take part in interviews or group discussions, and researchers will review documentation and care records to understand how the changes progress.

The study may help improve leadership skills, strengthen support for evidence-based practice, and improve care for patients in both mental health and elder care settings. The results may also help other healthcare organizations adopt similar approaches.

The study follows strict ethical and data protection rules. Survey participation is voluntary, and all personal information will be handled securely and confidentially. The care practices being introduced are already recommended in Finland and are part of normal care.

02

Conditions studied

  • Leadership
  • Self-Harm
  • Malnutrition Elderly

Keywords

  • Implementation
  • Evidence-based practice
  • Nursing
  • Leadership
03

In context

Self-Injurious Behavior

249 studies on the registry are indexed under Self-Injurious Behavior; 92 are open to participants now.

This study's planned enrollment of 300 is above the median of 66 across 212 interventional studies indexed under Self-Injurious Behavior.

Browse Self-Injurious Behavior studies →

Lead sponsor

This is the only study on the registry with Jaakko Varpula as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Nurse manager
  • Registered nurse
  • Practical nurse
  • Nurse director

Exclusion criteria

Exclusion Criteria:

  • Other healtcare professionals
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
300 participants (estimated)

Study arms

  • Experimental
    Leadership and Organizational Change for Implementation (LOCI)

    LOCI (Leadership and Organizational Change for Implementation) is a structured leadership and organizational development strategy designed to help managers strengthen their skills in implementing evidence-based practices. It combines leadership training, individualized mentoring, and organizational support to create a workplace climate that makes it easier to adopt and sustain new, research-based ways of working.

    Behavioral: Leadership and organizational change for implementation

Interventions

  • BehavioralLeadership and organizational change for implementation

    LOCI (Leadership and Organizational Change for Implementation) is a structured leadership and organizational development strategy designed to help managers strengthen their skills in implementing evidence-based practices. It combines leadership training, individualized mentoring, and organizational support to create a workplace climate that makes it easier to adopt and sustain new, research-based ways of working.

06

What researchers measure

Primary outcomes

  1. Acceptability

    Acceptability of Intervention Measure (AIM), 4-item, 5-point Likert Scale (1-5), Min score 5, Max score 20. Higher scores indicate greater acceptability.

    Time frame: 3months after start of intervention, 9 months (end of intervention)

  2. Appropriateness

    Intervention Appropriateness Measure (IAM), 4-item, 5-point Likert scale (1-5), Min score 5, Max score 20. Higher scores indicate greater appropriateness.

    Time frame: 3months after start of intervention, 9 months (end of intervention)

  3. Feasibility of intervention

    Feasibility of Intervention Measure (FIM), 4-item, 5-point Likert scale (1-5), Min score 5, Xax score 20. Higher scores indicate greater feasibility.

    Time frame: 3months after start of intervention, 9 months (end of intervention)

Secondary outcomes

  1. Effectiveness to implementation leadership

    Implementation leadership scale (ILS), 21-item, 5-point Likert scale (0-4). Min 0 and Max score 84. Higher scores indicate better implementation-supportive leadership.

    Time frame: Baseline, 3month, 8months, 3 month follow-up

  2. Effectiveness to transformational leadership

    Global Transformational Leadership Scale (GTL), 7-item, 5-point Likert Scale (1-5), Min 7, Max score 35, higher score indicate better outcome, more transformational leadership behaviours.

    Time frame: Baseline, 3month, 8months, 3 month follow-up

  3. Effectiveness to implementation climate

    Implementation Climate Scale (ICS), 27-item, 5-point Likert scale (0-4), Min 0, Max score 108, higher scores indicate better outcomes - stronger organizational climate supporting evidence-based practice implementation.

    Time frame: Baseline, 3month, 8months, 3 month follow-up

  4. Effectiveness to evidence-based practice attitudes

    The Evidence-based Practice Attitude Scale (EBPAS), 15-item, 5-point Likert Scale (0-4). Min 0, Max score 60, higher scores indicate better outcome, more positive atittudes towards evidence-based practice.

    Time frame: Baseline, 3month, 8months, 3 month follow-up

07

Study locations

1 of 1 sites recruiting
  • The Wellbeing Services Country of Southwest Finland
    Turku, Finland
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — De-identified instrument-level data derived from questionnaires (ILS, GTL, ICS, EBPAS, AIM, IAM, FIM) completed by staff participants will be shared. These datasets will include item-level responses but will exclude any direct identifiers or variables that could reasonably enable re-identification.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07378696
Lead sponsor
Jaakko Varpula
Responsible party
Jaakko Varpula (Postdoctoral researcher, University of Turku) — Sponsor-investigator
First posted
Jan 30, 2026
Start date
Jan 15, 2026
Primary completion
Jan 2027 (estimated)
Completion
Jan 2027 (estimated)
Last update
Feb 5, 2026

Study contacts

Jaakko Varpula, PhD
Contact
jaheva@utu.fi
+358442784794
Riitta Askola, PhD
Contact
raasko@utu.fi
+358505715760
Anna Axelin, Professor
study director · University of Turku, Department of Nursing Science

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion